Yves Leestemaker
Impact in
Papers in
-
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 2
- Glycosylation and Glycoproteins Research 1
- Oncology 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Huib Ovaa (7 shared papers)J. Bernd Helms (1 shared paper)Martin Giera (1 shared paper)Lauren Fong (1 shared paper)Evelyne Steenvoorden (1 shared paper)Anne G. Bang (1 shared paper)Lawrence S.B. Goldstein (1 shared paper)Vanessa F. Langness (1 shared paper)
- Journals
- Cell stem cell (1 paper)The Journal of Immunology (1 paper)Frontiers in Molecular Biosciences (1 paper)Molecular Pharmaceutics (1 paper)Drug Discovery Today Technologies (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Yves Leestemaker
7 papers receiving 491 citations
Peers
Comparison fields: 5 of 66
- Biological Psychiatry 15
- Aging 9
- Molecular Biology 348
- Physiology 131
- Neurology 39
Countries citing papers authored by Yves Leestemaker
This map shows the geographic impact of Yves Leestemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Leestemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Leestemaker more than expected).
Fields of papers citing papers by Yves Leestemaker
This network shows the impact of papers produced by Yves Leestemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Leestemaker. The network helps show where Yves Leestemaker may publish in the future.
Co-authors
The 25 scholars most cited alongside Yves Leestemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 231 | |
| 2 | 2017 | 117 | |
| 3 | 2017 | 66 | |
| 4 | 2012 | 37 | |
| 5 | 2019 | 30 | |
| 6 | 2017 | 13 | |
| 7 | 2016 | 4 |
About Yves Leestemaker
Yves Leestemaker is a scholar working on Molecular Biology, Oncology, Surgery, Biological Psychiatry and Hematology, having authored 7 papers that have together received 498 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Tryptophan and brain disorders (1 paper), Alzheimer's disease research and treatments (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Biological Psychiatry (15 citations), Aging (9 citations), Molecular Biology (348 citations), Physiology (131 citations) and Neurology (39 citations). Yves Leestemaker has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Huib Ovaa, J. Bernd Helms, Martin Giera, Lauren Fong, Evelyne Steenvoorden, Anne G. Bang, Lawrence S.B. Goldstein, Vanessa F. Langness, Rik van der Kant and Jos F. Brouwers. Their work appears in journals such as Cell stem cell, The Journal of Immunology, Frontiers in Molecular Biosciences, Molecular Pharmaceutics and Drug Discovery Today Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.